US FDA grants Breakthrough Therapy designation to...
Category : ODD/BTA/FTA Status 20 March 2026Sanofi announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy des...
Odd Bta Fta Status
FDA Grants Breakthrough Therapy Designation to Sut...
Category : ODD/BTA/FTA Status 8 March 2026Hemab Therapeutics has received a major regulatory boost after the U.S. Food and Drug Administration...
Veloxis’ VEL-101 Granted FDA Orphan Drug Designati...
Category : ODD/BTA/FTA Status 22 January 2026Veloxis Pharmaceuticals, Inc., a global specialty pharmaceutical company and part of Asahi Kasei Cor...
Ionis Pharmaceuticals Secures FDA Breakthrough The...
Category : ODD/BTA/FTA Status 5 December 2025Ionis Pharmaceuticals has achieved a major regulatory milestone with the U.S. FDA granting Breakthro...
FDA Grants Fast Track Status to VS-041, a Novel MM...
Category : ODD/BTA/FTA Status 19 November 2025Vasa Therapeutics has received FDA Fast Track designation for VS-041, its lead investigational small...
Latest Newsletter Post
-
US FDA grants Breakthrough Therapy..
20 March 2026
-
Sobi presents positive results from..
20 March 2026
-
A New Playbook for Ulcerative Colit..
19 March 2026
-
Aspen Neuroscience’s Cell Therapy S..
19 March 2026
-
Rhythm’s EMANATE Trial Misses the M..
19 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com